|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
multiple interactions |
ISO |
sulindac sulfone binds to and results in decreased activity of AKR1B1 protein |
CTD |
PMID:25532697 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
multiple interactions |
ISO |
sulindac sulfone binds to and results in decreased activity of AKR1B10 protein |
CTD |
PMID:25532697 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
affects phosphorylation multiple interactions |
ISO EXP |
sulindac sulfone affects the phosphorylation of AKT1 protein [Celecoxib co-treated with sulindac sulfone] results in decreased expression of AKT1 protein; [Celecoxib co-treated with sulindac sulfone] results in decreased expression of AKT1 protein modified form |
CTD |
PMID:15570007 PMID:17908994 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
multiple interactions increases expression |
ISO |
8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [sulindac sulfone results in increased phosphorylation of ALOX15 protein]; GATA6 protein inhibits the reaction [sulindac sulfone results in increased expression of ALOX15 protein] sulindac sulfone results in increased expression of ALOX15 mRNA; sulindac sulfone results in increased expression of ALOX15 protein |
CTD |
PMID:11861401 PMID:16166323 |
|
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO EXP |
AR protein affects the reaction [sulindac sulfone results in decreased expression of KLK3 protein]; sulindac sulfone results in decreased expression of and results in decreased activity of AR protein [Celecoxib co-treated with sulindac sulfone] results in decreased expression of AR protein |
CTD |
PMID:14581372 PMID:17908994 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases response to substance |
EXP |
BAK1 results in increased susceptibility to sulindac sulfone |
CTD |
PMID:18349538 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO |
MAP2K1 protein inhibits the reaction [sulindac sulfone results in increased cleavage of and results in increased activity of CASP3 protein]; sulindac sulfone results in increased cleavage of and results in increased activity of CASP3 protein sulindac sulfone results in increased activity of CASP3 protein |
CTD |
PMID:11051267 PMID:14555707 PMID:15548677 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
sulindac sulfone results in increased activity of CASP8 protein |
CTD |
PMID:11559570 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression multiple interactions |
ISO EXP |
sulindac sulfone results in decreased expression of CCND1 mRNA; sulindac sulfone results in decreased expression of CCND1 protein [Celecoxib co-treated with sulindac sulfone] results in decreased expression of CCND1 protein |
CTD |
PMID:12392815 PMID:15188006 PMID:17908994 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
sulindac sulfone results in increased expression of CDKN1A mRNA; sulindac sulfone results in increased expression of CDKN1A protein |
CTD |
PMID:18593937 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
ISO |
sulindac sulfone results in increased expression of CDKN1B mRNA; sulindac sulfone results in increased expression of CDKN1B protein |
CTD |
PMID:18593937 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions decreases expression increases expression |
ISO |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfone results in decreased expression of CTNNB1 protein] sulindac sulfone results in increased expression of CTNNB1 protein |
CTD |
PMID:10910034 PMID:11602670 PMID:12392815 PMID:14555707 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions decreases expression decreases phosphorylation increases phosphorylation increases ubiquitination |
ISO EXP |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfone results in decreased expression of EGFR protein]; Chloroquine inhibits the reaction [sulindac sulfone results in decreased expression of EGFR protein] sulindac sulfone results in decreased phosphorylation of EGFR protein sulindac sulfone results in increased phosphorylation of EGFR protein [Celecoxib co-treated with sulindac sulfone] results in decreased expression of EGFR protein; [Celecoxib co-treated with sulindac sulfone] results in decreased expression of EGFR protein modified form sulindac sulfone results in increased ubiquitination of EGFR protein |
CTD |
PMID:17908994 PMID:20332299 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
decreases expression |
ISO |
sulindac sulfone results in decreased expression of ERBB2 protein |
CTD |
PMID:20332299 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
multiple interactions decreases expression |
ISO |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfone results in decreased expression of ERBB3 protein] |
CTD |
PMID:20332299 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression |
ISO |
sulindac sulfone results in decreased expression of ESR1 mRNA; sulindac sulfone results in decreased expression of ESR1 protein |
CTD |
PMID:16740773 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Gata6 |
GATA binding protein 6 |
multiple interactions decreases expression |
ISO |
GATA6 protein inhibits the reaction [sulindac sulfone results in increased expression of ALOX15 protein] sulindac sulfone results in decreased expression of GATA6 protein |
CTD |
PMID:11861401 |
|
NCBI chr18:2,188,121...2,219,532
Ensembl chr18:2,188,121...2,219,532
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
ISO |
sulindac sulfone binds to and results in decreased activity of GSTP1 protein |
CTD |
PMID:15300575 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hint1 |
histidine triad nucleotide binding protein 1 |
increases expression |
ISO |
sulindac sulfone results in increased expression of HINT1 mRNA; sulindac sulfone results in increased expression of HINT1 protein |
CTD |
PMID:18593937 |
|
NCBI chr10:38,989,516...38,993,259
Ensembl chr 4:92,100,973...92,101,568
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
increases activity increases expression |
ISO |
sulindac sulfone results in increased activity of HPGD protein sulindac sulfone results in increased expression of HPGD mRNA |
CTD |
PMID:19501039 |
|
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
|
|
G |
Il24 |
interleukin 24 |
increases expression |
ISO |
sulindac sulfone results in increased expression of IL24 protein |
CTD |
PMID:15713900 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
multiple interactions decreases expression |
ISO |
AR protein affects the reaction [sulindac sulfone results in decreased expression of KLK3 protein] |
CTD |
PMID:11490238 PMID:14581372 |
|
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
multiple interactions |
ISO |
MAP2K1 protein inhibits the reaction [sulindac sulfone results in decreased phosphorylation of MAPK1 protein]; MAP2K1 protein inhibits the reaction [sulindac sulfone results in decreased phosphorylation of MAPK3 protein]; MAP2K1 protein inhibits the reaction [sulindac sulfone results in increased cleavage of and results in increased activity of CASP3 protein] |
CTD |
PMID:15548677 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
multiple interactions |
ISO |
sulindac sulfone results in increased phosphorylation of and results in increased activity of MAP2K4 protein |
CTD |
PMID:11051267 |
|
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
MAP2K1 protein inhibits the reaction [sulindac sulfone results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:15548677 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases phosphorylation |
ISO |
MAP2K1 protein inhibits the reaction [sulindac sulfone results in decreased phosphorylation of MAPK3 protein] |
CTD |
PMID:15548677 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases activity |
ISO |
sulindac sulfone results in increased activity of MAPK8 protein |
CTD |
PMID:11051267 PMID:11278263 PMID:15970671 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
decreases expression |
ISO |
sulindac sulfone results in decreased expression of MMP7 protein |
CTD |
PMID:15725655 |
|
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
sulindac sulfone results in increased degradation of and results in decreased expression of NFKBIA protein |
CTD |
PMID:18059344 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Ngfr |
nerve growth factor receptor |
increases expression |
ISO |
sulindac sulfone results in increased expression of NGFR mRNA; sulindac sulfone results in increased expression of NGFR protein |
CTD |
PMID:17447067 |
|
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity increases expression |
ISO |
sulindac sulfone results in increased activity of NQO1 protein sulindac sulfone results in increased expression of NQO1 mRNA |
CTD |
PMID:17985343 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
sulindac sulfone results in decreased expression of PCNA protein |
CTD |
PMID:15570007 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pde2a |
phosphodiesterase 2A |
decreases activity multiple interactions |
ISO |
sulindac sulfone results in decreased activity of PDE2A protein sulindac sulfone binds to and results in decreased activity of PDE2A protein |
CTD |
PMID:10910034 PMID:11602670 |
|
NCBI chr 1:155,823,590...155,915,434
Ensembl chr 1:155,813,180...155,915,434
|
|
G |
Pde5a |
phosphodiesterase 5A |
multiple interactions decreases activity |
ISO |
sulindac sulfone binds to and results in decreased activity of PDE5A protein sulindac sulfone results in decreased activity of PDE5A protein |
CTD |
PMID:10910034 PMID:11602670 |
|
NCBI chr 2:210,858,515...211,003,480
Ensembl chr 2:210,858,063...210,999,701
|
|
G |
Pgr |
progesterone receptor |
decreases expression |
ISO |
sulindac sulfone results in decreased expression of PGR mRNA; sulindac sulfone results in decreased expression of PGR protein |
CTD |
PMID:16740773 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
increases expression |
ISO |
sulindac sulfone results in increased expression of PPARA mRNA |
CTD |
PMID:11948457 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
increases expression |
ISO |
sulindac sulfone results in increased expression of PPARD mRNA |
CTD |
PMID:11948457 |
|
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions increases expression |
ISO |
[sulindac sulfone results in increased activity of PPARG protein] promotes the reaction [PPARG protein binds to SAT1 enhancer]; PPARG protein promotes the reaction [sulindac sulfone results in increased expression of SAT1 mRNA] sulindac sulfone results in increased expression of PPARG mRNA |
CTD |
PMID:11948457 PMID:14506281 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
increases expression |
ISO |
sulindac sulfone results in increased expression of PRKG1 protein |
CTD |
PMID:11602670 PMID:16731751 |
|
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
|
|
G |
Psca |
prostate stem cell antigen |
increases expression |
ISO |
sulindac sulfone results in increased expression of PSCA mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 7:106,598,203...106,603,114
Ensembl chr 7:106,595,284...106,609,746
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
decreases expression |
EXP |
sulindac sulfone results in decreased expression of PTGS1 mRNA alternative form |
CTD |
PMID:11375891 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression increases expression multiple interactions |
ISO EXP |
sulindac sulfone results in decreased expression of PTGS2 protein sulindac sulfone results in increased expression of PTGS2 mRNA [sulindac sulfone results in decreased expression of PTGS2 protein] which results in decreased chemical synthesis of Dinoprostone [Celecoxib co-treated with sulindac sulfone] results in decreased expression of PTGS2 protein; Celecoxib promotes the reaction [sulindac sulfone results in decreased expression of PTGS2 protein] sulindac sulfone results in decreased expression of PTGS2 mRNA |
CTD |
PMID:11118042 PMID:11375891 PMID:11948457 PMID:17908994 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
affects localization |
ISO |
sulindac sulfone affects the localization of RELA protein |
CTD |
PMID:18059344 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
multiple interactions increases expression |
ISO |
[sulindac sulfone results in increased activity of PPARG protein] promotes the reaction [PPARG protein binds to SAT1 enhancer]; PPARG protein promotes the reaction [sulindac sulfone results in increased expression of SAT1 mRNA] |
CTD |
PMID:14506281 PMID:16262603 |
|
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
Celecoxib promotes the reaction [sulindac sulfone results in decreased expression of TNF protein] |
CTD |
PMID:17908994 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases activity increases expression increases glucuronidation |
ISO |
sulindac sulfone results in increased activity of UGT1A1 protein sulindac sulfone results in increased expression of UGT1A1 mRNA UGT1A1 protein results in increased glucuronidation of sulindac sulfone |
CTD |
PMID:15843492 PMID:17985343 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
increases glucuronidation |
ISO |
UGT1A3 protein results in increased glucuronidation of sulindac sulfone |
CTD |
PMID:15843492 |
|
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a5 |
UDP glucuronosyltransferase family 1 member A5 |
increases glucuronidation |
ISO |
UGT1A4 protein results in increased glucuronidation of sulindac sulfone |
CTD |
PMID:15843492 |
|
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
increases glucuronidation |
ISO |
UGT2B7 protein results in increased glucuronidation of sulindac sulfone |
CTD |
PMID:15843492 |
|
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
|
|
G |
Vasp |
vasodilator-stimulated phosphoprotein |
increases phosphorylation |
ISO |
sulindac sulfone results in increased phosphorylation of VASP protein |
CTD |
PMID:16166323 |
|
NCBI chr 1:78,910,009...78,925,791
Ensembl chr 1:78,910,011...78,925,061
|
|
G |
Ywhae |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon |
decreases expression |
ISO |
sulindac sulfone results in decreased expression of YWHAE protein |
CTD |
PMID:17409426 |
|
NCBI chr10:60,584,665...60,622,352
Ensembl chr10:60,584,652...60,671,589
|
|